M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer

Pancreatic cancer is a malignant disease with high mortality and poor prognosis due to lack of early diagnosis and low treatment efficiency after diagnosis. Although Gemcitabine (GEM) is used as the first-line chemotherapeutic drug, chemoresistance is still the major problem that limits its therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yongmei, Zheng, Yuanlin, Zhu, Yan, Zhang, Yi, Zhu, Hongyan, Liu, Tianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472397/
https://www.ncbi.nlm.nih.gov/pubmed/34575569
http://dx.doi.org/10.3390/pharmaceutics13091493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472397/
https://www.ncbi.nlm.nih.gov/pubmed/34575569
http://dx.doi.org/10.3390/pharmaceutics13091493

Ejemplares similares